Remus Pharmaceuticals Limited IPO
Remus focuses on marketing, distributing and exporting top-of-the-line complex generics certified by regulatory authorities. Backed by expert scientists, we make “healing through medicines” globally affordable. For over a decade, Remus has been at the forefront of critical healthcare globally.
| Event | Minimum | Maximum |
|---|---|---|
| Lot | 1 | 1 |
| Shares | 100 | 100 |
| Amount | ₹1,22,900 | ₹1,22,900 |
| Company Name | Symbol | Listing Exchange | Issue Size | IPO Open Date | IPO Closing Date | IPO Listing Date |
|---|---|---|---|---|---|---|
| Remus Pharmaceuticals Limited | REMUS | NSE, SME | 3,88,000 | 17 May 23 | 19 May 23 | 29 May 23 |
| Face Value | Pre Issue Share Holding | Post Issue Share Holding | Allotment Date | Refunds Date | Shares Credit in demat Date |
|---|---|---|---|---|---|
| ₹10 per share | 92.82% | 68.37% | 24 May 23 | 25 May 23 | 26 May 23 |
No comments:
Post a Comment